Internet-delivered cognitive behavioural therapy for major depressive disorder and anxiety disorders: Health technology assessment -- project protocol

CADTH, in collaboration with Health Quality Ontario (HQO), is undertaking an Optimal Use project on the use of iCBT in patients with mild and moderate major depressive disorder (MDD) and anxiety disorders. Collaboratively, both organizations will explore relevant clinical, economic, social, and ethi...

Full description

Bibliographic Details
Corporate Author: Canadian Agency for Drugs and Technologies in Health
Format: eBook
Language:English
Published: Ottawa CADTH 2018, June 2018
Series:CADTH optimal use report
Subjects:
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
LEADER 02220nam a2200325 u 4500
001 EB002000943
003 EBX01000000000000001163844
005 00000000000000.0
007 tu|||||||||||||||||||||
008 210907 r ||| eng
245 0 0 |a Internet-delivered cognitive behavioural therapy for major depressive disorder and anxiety disorders: Health technology assessment -- project protocol  |h Elektronische Ressource 
246 3 1 |a Health technology assessment -- project protocol 
260 |a Ottawa  |b CADTH  |c 2018, June 2018 
300 |a 1 PDF file (24 pages) 
505 0 |a Includes bibliographical references 
653 |a Telemedicine 
653 |a Depressive Disorder, Major / therapy 
653 |a Canada 
653 |a Anxiety Disorders / therapy 
653 |a Technology Assessment, Biomedical 
653 |a Cognitive Behavioral Therapy 
710 2 |a Canadian Agency for Drugs and Technologies in Health 
041 0 7 |a eng  |2 ISO 639-2 
989 |b NCBI  |a National Center for Biotechnology Information 
490 0 |a CADTH optimal use report 
500 |a "PROSPERO Registration Number: CRD42018096042"--PDF title page 
856 4 0 |u https://www.ncbi.nlm.nih.gov/books/NBK542845  |3 Volltext  |n NLM Bookshelf Books  |3 Volltext 
082 0 |a 610 
082 0 |a 600 
520 |a CADTH, in collaboration with Health Quality Ontario (HQO), is undertaking an Optimal Use project on the use of iCBT in patients with mild and moderate major depressive disorder (MDD) and anxiety disorders. Collaboratively, both organizations will explore relevant clinical, economic, social, and ethical evidence to inform the policy question. Analyses of the evidence will be presented in separate chapters, each with specific and different research questions and methodologies. HQO will develop a systematic review to assess the clinical effectiveness and cost-effectiveness of iCBT, as well as an economic analysis, and will undertake direct patient engagement to explore patient preferences and values. CADTH will develop reviews and analyses to assess patient perspectives and experiences, and ethical and implementation issues related to iCBT. This document outlines the research questions and methods to be used by CADTH.